Glycolipid entries from the LIPID MAPS Structure Database (LMSD).
Source | Last Updated |
---|---|
LIPID MAPS Proteome Database (LMSD) | June 16, 2024 |
Main Class | Sub Class | LM ID | Name ▲ | LipidBank ID | KEGG ID | PubChem CID | ChEBI ID | Exact Mass | Formula |
---|---|---|---|---|---|---|---|---|---|
Neutral glycosphingolipids | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) | LMSP0503AD07 |
|
44260514 | 1701.991692 | C82H147N3O33 | |||
Neutral glycosphingolipids | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) | LMSP0503AD06 |
|
44260513 | 1732.038642 | C84H153N3O33 | |||
Neutral glycosphingolipids | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) | LMSP0503AD08 |
|
44260515 | 1730.022992 | C84H151N3O33 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EK00 |
|
||||||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CF00 |
|
||||||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CF01 |
|
44261428 | 1591.882142 | C74H133N3O33 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CF02 |
|
44261429 | 1619.913442 | C76H137N3O33 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CF03 |
|
44261430 | 1647.944742 | C78H141N3O33 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CF04 |
|
44261431 | 1675.976042 | C80H145N3O33 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CF05 |
|
44261432 | 1704.007342 | C82H149N3O33 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CF07 |
|
44261434 | 1701.991692 | C82H147N3O33 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CF06 |
|
44261433 | 1732.038642 | C84H153N3O33 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CF08 |
|
44261435 | 1730.022992 | C84H151N3O33 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CL00 |
|
||||||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CL01 |
|
44261476 | 2103.072251 | C94H166N4O47 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CL02 |
|
44261477 | 2131.103551 | C96H170N4O47 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CL03 |
|
44261478 | 2159.134851 | C98H174N4O47 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CL04 |
|
44261479 | 2187.166151 | C100H178N4O47 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CL05 |
|
44261480 | 2215.197451 | C102H182N4O47 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CL07 |
|
44261482 | 2213.181801 | C102H180N4O47 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CL06 |
|
44261481 | 2243.228751 | C104H186N4O47 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CL08 |
|
44261483 | 2241.213101 | C104H184N4O47 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505BO00 |
|
||||||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505BO01 |
|
44261292 | 2119.067166 | C94H166N4O48 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505BO02 |
|
44261293 | 2147.098466 | C96H170N4O48 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024